Gain access to actionable insights from our expert analysts

GlobalData's Expert Insights provide an analyst's view of the latest trends and events in the pharmaceuticals and medical devices industry. Shining an informed light on recent acquisitions, drug approvals and industry crises, Expert Insights are substantiated by quantitative data and market forecasts taken from our own proprietary research.

Flying High with Balloons
Published: 17 Jun 2013
Drug-eluting balloons (DEB) have emerged as a potential therapeutic option for the treatment of patients with coronary and peripheral artery disease. Complications such as in-stent restenosis and thrombosis have prompted development of innovative technologies for improved solutions, such as local drug-delivery via non stent-based platforms.
The SNMMI 2013 Image of the Year: Empowering Personalized Medicine
Published: 13 Jun 2013
A study using PET/CT scans to demonstrate the effectiveness of radium-223 dichloride to treat breast cancer patients with bone metastases was chosen as the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2013 Image of the Year, during the SNMMI’s 2013 Annual Meeting in Vancouver, British Columbia, which was held from June 8–12. Patrick Flamen from the Jules Bordet Institute in Belgium presented the results of a study demonstrating, using PET/CT scans, that after two treatments with radium-223 dichloride, 32% of the target lesions decreased significantly.
Shoulder Replacement Market: Reverse, Reverse, and More Reverse
Published: 12 Jun 2013
While the economic recession has severely dampened most orthopedic companies’ top-line sales, such as hip and knee replacements, its lingering impact on extremity devices is not as prevalent as in the large-joint markets. For example, shoulder replacement, currently the third biggest joint replacement market, has enjoyed significant expansion in the past few years.
Valve-in-Valve Technology Approval Opens New Door for Sales
Published: 30 May 2013
Medtronic recently received CE Mark approval for the use of its next-generation CoreValve transcatheter aortic valve replacement (TAVR) device in patients with a pre-existing valve implant already in place. Known as valve-in-valve (VIV) implantation, this technique is used when a patient’s previously implanted replacement valve wears out or is not functioning properly; physicians deploy a subcutaneously-delivered new replacement valve in series with the old valve device.
Quality of Care Is the Key to Continued Growth in Medical Tourism Market
Published: 09 May 2013
While surgical costs remain the driving force behind the adoption of medical tourism in the short term, the quality of medical care in these countries will become the paramount differentiator in the long run. The rising healthcare costs in the major developed economies of North America and Europe have led to the growing adoption of medical tourism.